Search
Novo Nordisk Shares Tumble 21%: Intensifying Competition in Weight-Loss Drugs Prompts Second Downgrade of Performance Outlook
2025-07-30 /
Read about 0 minute
Author：小编
Novo Nordisk has downgraded its performance guidance, resulting in a steep decline in its share price and an erosion of over US$50 billion in market value.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
